Trispecific T-cell engagers for dual tumor-targeting of colorectal cancer

Retargeting of T lymphocytes toward cancer cells by bispecific antibodies has demonstrated its therapeutic potential, with one such antibody approved for the treatment of acute lymphoblastic leukemia (blinatumomab) and several other in clinical trials. However, improvement of their efficacy and sele...

Descripción completa

Detalles Bibliográficos
Autores principales: Tapia-Galisteo, Antonio, Sánchez Rodríguez, Íñigo, Aguilar-Sopeña, Oscar, Harwood, Seandean Lykke, Narbona, Javier, Ferreras Gutierrez, Mariola, Navarro, Rocío, Martín-García, Laura, Corbacho, Cesáreo, Compte, Marta, Lacadena, Javier, Blanco, Francisco J., Chames, Patrick, Roda-Navarro, Pedro, Álvarez-Vallina, Luis, Sanz, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837253/
https://www.ncbi.nlm.nih.gov/pubmed/35154908
http://dx.doi.org/10.1080/2162402X.2022.2034355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837253/
https://www.ncbi.nlm.nih.gov/pubmed/35154908
http://dx.doi.org/10.1080/2162402X.2022.2034355

Ejemplares similares